1. Home
  2. BRTX vs FGI Comparison

BRTX vs FGI Comparison

Compare BRTX & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • FGI
  • Stock Information
  • Founded
  • BRTX 1997
  • FGI 1987
  • Country
  • BRTX United States
  • FGI United States
  • Employees
  • BRTX N/A
  • FGI N/A
  • Industry
  • BRTX Managed Health Care
  • FGI Industrial Specialties
  • Sector
  • BRTX Health Care
  • FGI Industrials
  • Exchange
  • BRTX Nasdaq
  • FGI Nasdaq
  • Market Cap
  • BRTX 12.8M
  • FGI 10.4M
  • IPO Year
  • BRTX N/A
  • FGI 2022
  • Fundamental
  • Price
  • BRTX $1.50
  • FGI $5.36
  • Analyst Decision
  • BRTX
  • FGI
  • Analyst Count
  • BRTX 0
  • FGI 0
  • Target Price
  • BRTX N/A
  • FGI N/A
  • AVG Volume (30 Days)
  • BRTX 304.1K
  • FGI 923.9K
  • Earning Date
  • BRTX 11-13-2025
  • FGI 11-05-2025
  • Dividend Yield
  • BRTX N/A
  • FGI N/A
  • EPS Growth
  • BRTX N/A
  • FGI N/A
  • EPS
  • BRTX N/A
  • FGI N/A
  • Revenue
  • BRTX $605,200.00
  • FGI $135,904,413.00
  • Revenue This Year
  • BRTX $232.67
  • FGI $5.57
  • Revenue Next Year
  • BRTX $52.92
  • FGI $8.02
  • P/E Ratio
  • BRTX N/A
  • FGI N/A
  • Revenue Growth
  • BRTX 247.62
  • FGI 12.30
  • 52 Week Low
  • BRTX $1.19
  • FGI $2.28
  • 52 Week High
  • BRTX $2.55
  • FGI $12.62
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 42.27
  • FGI 48.41
  • Support Level
  • BRTX $1.49
  • FGI $4.93
  • Resistance Level
  • BRTX $1.70
  • FGI $5.60
  • Average True Range (ATR)
  • BRTX 0.09
  • FGI 0.59
  • MACD
  • BRTX -0.01
  • FGI -0.09
  • Stochastic Oscillator
  • BRTX 14.81
  • FGI 32.41

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

Share on Social Networks: